Breaking News, Trials & Filings

Trials & Filings in Brief: Oct. 30, 2013

Acacia, Flexion, GSK KaloBios, MannKind, Merrimack, RedHill, Spectrum, Theravance

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase II Acacia begins CINV trial . . . read more Flexion posts good OA results . . . read more Merrimack ovarian cancer treatment falls short . . . read more Spectrum completes enrollment for melphalan trial . . . read more Phase III RedHill starts H.pylori trial . . . read more Filings KaloBios gets orphan designation for CF treatment . . . read more FDA Accepts Afrezza Submission . . . read more Launches GSK, Theravance launch Breo Ellipta . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters